grant

Dissecting host-virus interactions in epithelial cells

Organization UNIVERSITY OF CALIFORNIA, SAN DIEGOLocation LA JOLLA, UNITED STATESPosted 1 Nov 2024Deadline 31 Oct 2027
NIHUS FederalResearch GrantFY2026AddressAffinityAnimal ModelAnimal Models and Related StudiesAntigenic DeterminantsAssayAutoimmune DiseasesBase SequenceBinding DeterminantsBioassayBiological AssayBiological FunctionBiological ProcessBody SurfaceBody TissuesC elegansC. elegansC.elegansCaenorhabditis elegansCell BodyCell Communication and SignalingCell SignalingCellsCommunicable DiseasesDefense MechanismsDouble-Stranded RNAEpithelial CellsEpitheliumEpitopesExposure toGene TranscriptionGeneHomologGeneticGenetic TranscriptionGenetics-MutagenesisGoalsHomologHomologous GeneHomologueHumanIFNIFN-regulatory factor 3IRF-3 proteinIRF3IRF3 geneImmuneImmune responseImmune signalingImmunesImmunityInfectionInfectious DiseasesInfectious DisorderInnate Immune ResponseInterferon Regulatory Factor 3Interferon Type IInterferonsIntestinalIntestinesIntracellular Communication and SignalingInvadedKnowledgeLabelLocationMammaliaMammalsMediatingMethodsMitochondriaModelingModern ManMolecularMutagenesisMutagenesis Molecular BiologyN-terminalNH2-terminalNematodaNematodesNucleotide SequenceOutcomePathway interactionsPattern recognition receptorPost-Transcriptional Gene SilencingRNA ExpressionRNA HelicaseRNA InterferenceRNA SeqRNA SilencingRNA replicationRNA sequencingRNAiRNAseqReceptor ProteinReceptor SignalingRegulationResistanceRoleSequence-Specific Posttranscriptional Gene SilencingShapesSignal PathwaySignal TransductionSignal Transduction SystemsSignalingSpecificityTestingTissuesTranscriptionViralViral DiseasesVirusVirus DiseasesWorkanti-viral immunityantiviral immunityautoimmune conditionautoimmune disorderautoimmunity diseasebiological signal transductionbowelcell typedsRNAenteral pathogenenteric pathogenenteropathogenexperimentexperimental researchexperimental studyexperimentshost responseimmune system responseimmunoresponsein vivoinnovateinnovationinnovativeinsightintestinal epitheliumintestinal pathogenintestine pathogenmitochondrialmodel of animalnovelnucleic acid sequenceoverexpressoverexpressionpathogenpathwayprogramsprotein protein interactionpsychological defense mechanismreceptorreceptor-mediated signalingresistantresponseroundwormscreeningscreeningssensorsocial roletooltranscriptome sequencingtranscriptomic sequencingtranslational impactviral RNAviral detectionviral infectionvirus RNAvirus detectionvirus host interactionvirus infectionvirus-induced disease
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

ABSTRACT
Epithelial cells are exposed to a wide range of environmental pathogens due to their location at body

surfaces. Aside from functioning as a physical barrier, epithelial cells also coordinate immune defenses through

receptor-mediated signaling. However, we do not fully understand the mechanisms that shape pathogen

recognition and immune signaling in epithelial cells. The overall goal of this proposal is to elucidate the molecular

mechanisms that regulate the outcome of viral infection in epithelial cells. There is a critical need for an in vivo

animal model that facilitates mechanistic studies of epithelial immunity. Infection with Orsay virus–a naturally

occurring intestinal pathogen of the nematode Caenorhabditis elegans–provides an innovative approach to study

cellular interactions between a virus and its natural host in the context of a whole-animal model. An obligate,

intracellular pathogen, Orsay virus invades C. elegans intestinal cells and induces the activation of the

Intracellular Pathogen Response (IPR), a transcriptional defense program that confers pathogen resistance

(Sowa et al. 2020). This antiviral transcriptional response requires DRH-1, a homolog of mammalian RIG-I-like

receptors (RLRs). RLRs are intracellular pattern-recognition receptors (PRRs) that detect viral RNA to initiate an

antiviral immune response. Notably, DRH-1/RLR is one of the few PRRs conserved between C. elegans and

humans. Despite the similarity between RLRs and DRH-1, C. elegans lacks sequence-based homologs to the

downstream signaling components of the RLR pathway–including MAVS, IRF3, NF-κB and interferon. It is

unclear which host determinants are involved in DRH-1-mediated activation of the IPR and where DRH-1 is

required to induce the IPR. The proposed studies integrate molecular tools and a natural infection model to

address the central hypothesis that DRH-1 signals through a non-canonical RLR signaling pathway and functions

in intestinal cells to induce the IPR. The central hypothesis will be tested through two specific aims. Aim 1.

Determine how DRH-1 signals to activate the Intracellular Pathogen Response. Aim 2. Define the tissue

specificity and subcellular localization of DRH-1 during Orsay virus infection. The expected outcome of this

project is a mechanistic understanding of how C. elegans DRH-1 coordinates host-virus interactions at the

epithelial barrier. This work will highlight either the evolutionary conservation or rewiring of RLR signaling in

epithelial cells. Collectively, the proposed studies will reveal a novel form of antiviral immunity in C. elegans.

More broadly, the proposed studies will have positive translational impact by elucidating a novel antiviral pathway

that may provide insight into the regulation of innate immune responses during viral infection in humans.

Grant Number: 5F31AI176729-02
NIH Institute/Center: NIH

Principal Investigator: Lakshmi Batachari

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →